Momelotinib (Ojjaara)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 14:17, 26 November 2014 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

JAK1/2 inhibitor

Preliminary data

Myelofibrosis

Pardanani A, Laborde RR, Lasho TL, Finke C, Begna K, Al-Kali A, Hogan WJ, Litzow MR, Leontovich A, Kowalski M, Tefferi A. Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis. Leukemia. 2013 Jun;27(6):1322-7. Epub 2013 Mar 5. PubMed

Retrieved from "https://hemonc.org/w/index.php?title=Momelotinib_(Ojjaara)&oldid=6070"